
FDA Approves Blueprint Medicines’ Ayvakit (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
First precision therapy that specifically targets the primary driver of the disease Durable clinical responses,
First precision therapy that specifically targets the primary driver of the disease Durable clinical responses,
Las últimas cifras de inscripción al Medicaid muestran que creció de 71,3 millones de miembros
BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and
SACRAMENTO — When Laura Chavez’s 74-year-old mom needed eye surgery last month, Chavez paid cash
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications
Pfizer’s management knew last year there was “a mold issue” at the Kansas facility now
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in
April 30 will mark the end of the first 100 days of President Joe Biden’s
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-MACROGOL PLUS
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BETALOC®INJECTION Metoprolol